[1] WHO. Meningococcal vaccines: WHO position paper, November 2011. Wkly Epidemiol Rec 2011;86(47):521-39. https://pubmed.ncbi.nlm.nih.gov/22128384/.
[2] Liu WT, Li JH, Ning GJ. Epidemiological characteristics of meningococcal meningitis in China, 2012-2014. Chin J Vaccin Immun 2016;22(2):149-52,179. https://zgjm.cbpt.cnki.net/WKD/WebPublication/paperDigest.aspx?paperID=e1444d89-8668-4c94-ac91-5974a378bb10. (In Chinese). 
[3] Zhang LN, Li KL, Du W, Li Y, Fan CX, Shi LB, et al. Surveillance of adverse events following immunization in China, 2018. Chin J Vaccin Immun 2020;26(4):363 − 71. https://doi.org/10.19914/j.cjvi.2020.04.002CrossRef
[4] Zhang LN, Li KL, Du W, Li Y, Fan CX, Yu WZ, et al. Surveillance of adverse events following immunization in China, 2019. Chin J Vaccin Immun 2021;27(4):438 − 45. https://doi.org/10.19914/j.CJVI.2021075CrossRef
[5] Lei JY, Balakrishnan MR, Gidudu JF, Zuber PLF. Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000-2015. Vaccine 2018;36(12):1577 − 82. https://doi.org/10.1016/j.vaccine.2018.02.012CrossRef
[6] Bloom DE, Bonanni P, Martinón-Torres F, Richmond PC, Safadi MAP, Salisbury DM, et al. Meningococcal disease in the post-COVID-19 era: a time to prepare. Infect Dis Ther 2023;12(12):2649 − 63. https://doi.org/10.1007/s40121-023-00888-wCrossRef
[7] Bermal N, Huang LM, Dubey AP, Jain H, Bavdekar A, Lin TY, et al. Safety and immunogenicity of a tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine in adolescents and adults. Hum Vaccin 2011;7(2):239 − 47. https://doi.org/10.4161/hv.7.2.14068CrossRef
[8] Li JR, Yang J, LIU XQ, Shi KY, Yang HT, Zheng WB, et al. Safety of post-marketing group A and C meningococcal conjugate and Haemophilus type b conjugate combined vaccine among children aged 2-71 months. Chin J Vaccin Immun 2016;22(5):578-81. https://zgjm.cbpt.cnki.net/WKD/WebPublication/paperDigest.aspx?paperID=4dd03fbf-3dbe-44e0-812a-784c94522ca4. (In Chinese). 
[9] Wu LL, Liu JC, Shao HY, Li Z, Yang JP, Sun XD. Surveillance and analysis of adverse events following immunization with meningococcus-containing vaccine in Shanghai, 2015-2018. Chin J Biologicals 2020;33(7):813 − 7. https://doi.org/10.13200/j.cnki.cjb.003105CrossRef
[10] Wu WD, Liu DW, Li KL, Xu DS, Ye JK, Zheng JS, et al. Study on surveillance data of adverse vaccine reactions for meningococcal vaccine in China, 2010-2012. Chin J Drug Eval 2014;31(2):117-21,128. http://qikan.cqvip.com/Qikan/Article/Detail?id=49849344. (In Chinese).